Recent Finacing
Recent Raise
Dermagnostix develops an automated microfluidics diagnostic platform—Analyzer and single‑use PsorX‑LabDisk cartridges—that delivers molecular psoriasis vs eczema differentiation within two hours and expands tests for skin diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor